Navigation Links
GeneGo and OmicSoft Announce Integration
Date:5/12/2009

ST. JOSEPH, Mich., May 12 /PRNewswire/ -- GeneGo, Inc., the leading provider of pathway data mining & analysis solutions, and OmicSoft Corporation, the premiere visualization and analysis software for the interpretation of high dimensional data, today announced the integration of the MetaCore(TM) pathway analysis platform with Array Studio.

"Array Studio is a powerful analysis platform and we have mutual customers that this integration will benefit," said Julie Bryant, VP of Business Development at GeneGo. "One of the key parts of this integration will be for users of Array Studio to easily access GeneGo's wealth of canonical pathway maps, in order to enhance their data analysis and hypothesis testing workflow."

"MetaCore integration with Array Studio will have an immediate impact for some of our mutual clients, taking the analysis results generated by Array Studio and moving it to the next level with GeneGo's pathway analysis tools," said Jack Liu, President at OmicSoft. "GeneGo's flexibility and collaborative thinking has made this a smooth integration, and we look forward to working more with them in the future."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.3(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.3(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.

About Array Studio and OmicSoft Corporation

OmicSoft Corporation focuses on biomarker data management, visualization, and analysis. To achieve this, OmicSoft has designed software that is easy to use by the bench scientists, but powerful enough to be used by the bioinformatician or statistician. OmicSoft's products are designed with the influence of all three groups, and thus are fast, powerful, and easy to use. OmicSoft currently markets Array Studio for analysis and Array Server as an enterprise solution.

Array Studio is a software package which provides state of the art statistics and visualization for the analysis of high dimensional quantification data (e.g. Microarray or Taqman data), genotype data (e.g. SNP data, Copy Number data). The software is designed for ease of use so that biologists can function at near the level of informatics specialists, providing the fastest, easiest, and most powerful solution on the market. Array Studio includes support for all popular microarray platforms (Affymetrix, Agilent, Illumina, etc.), as well as support for SNP/Genotype platforms (Affymetrix, Illumina, etc.), and Copy Number platforms (Affymetrix, Illumina, Agilent). It provides analysis modules for Exon/gene arrays, as well as an industry-leading Taqman import and normalization module. With over 40 unique, fully interactive, and highly customizable views, users can create exciting presentations through the program's seamless integration with Excel and PowerPoint.

For more information, please visit the company's website at www.omicsoft.com


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals
2. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
3. Elan Pharmaceuticals Joins GeneGos MetaTox Consortium
4. GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery
5. GeneGos First Customer in Hong Kong; The Chinese University of Hong Kong
6. KineMed Licenses GeneGos MetaCore
7. A*STARs Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: